Hypothesis
Loss of tropoelastin in aging vessels generates bioactive peptide fragments that normally suppress mTORC1 activity and inhibit Rubicon‑mediated blockade of autophagosome‑lysosome fusion. When tropoelastin declines, this inhibitory tone is lost, leading to mTORC1 hyperactivation, cytoplasmic sequestration of TFEB, and Rubicon upregulation—collectively suppressing autophagy. Restoring tropoelastin or its specific peptide domains should reactivate autophagy in vascular smooth muscle cells (VSMCs) by re‑engaging AKT‑dependent feedback inhibition of mTORC1 and reducing Rubicon expression.
Mechanistic Rationale
Extracellular matrix (ECM) proteins can act as signaling ligands through integrin receptors. Prior work shows exogenous tropoelastin delays senescence via AKT activation [3]. AKT phosphorylates and inhibits the TSC complex, which paradoxically can lead to feedback inhibition of mTORC1 through S6K‑mediated IRS‑1 inhibition—a well‑characterized homeostatic loop. We propose that tropoelastin‑derived peptides engage integrin‑αvβ3, triggering a transient AKT pulse that activates mTORC2‑dependent phosphorylation of FOXO3, which in turn transcriptionally represses Rubicon [2]. Simultaneously, AKT‑mediated phosphorylation of PRAS40 relieves its inhibition of mTORC1, but the ensuing S6K‑IRS‑1 negative feedback dampens mTORC1 signaling sufficiently to allow TFEB nuclear translocation [1]. This dual





























